Search

Author/Creator Forde, Patrick M

1. A first-in-human phase 1 dose escalation study of spartalizumab (PDR001), an anti–PD-1 antibody, in patients with advanced solid tumors. Issue 1 (15th March 2020)

Authors:
Naing, Aung; Gainor, Justin F; Gelderblom, Hans; Forde, Patrick M; Butler, Marcus O; Lin, Chia-Chi; Sharma, Sunil; Ochoa de Olza, Maria; Varga, Andrea; Taylor, Matthew; Schellens, Jan H M; Wu, Hongqian; Sun, Haiying; Silva, Antonio P; Faris, Jason; Mataraza, Jennifer; Cameron, Scott; Bauer, Todd M
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Anti-RA33 antibodies are present in a subset of patients with immune checkpoint inhibitor-induced inflammatory arthritis. Issue 2 (12th September 2022)

Authors:
Cappelli, Laura C; Bingham, Clifton O; Forde, Patrick M; Anagnostou, Valsamo; Brahmer, Julie; Lipson, Evan J; Mammen, Jennifer; Schollenberger, Megan; Shah, Ami A; Darrah, Erika
Journal:
RMD open
Issue:
Volume 8:Issue 2(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

3. Chronic immune checkpoint inhibitor pneumonitis. Issue 1 (17th June 2020)

Authors:
Naidoo, Jarushka; Cottrell, Tricia R; Lipson, Evan J; Forde, Patrick M; Illei, Peter B; Yarmus, Lonny B; Voong, K Ranh; Feller-Kopman, David; Lee, Hans; Riemer, Joanne; Wang, Daphne; Taube, Janis M; Brahmer, Julie R; Lin, Cheng Ting; Danoff, Sonye K; D'Alessio, Franco R; Suresh, Karthik
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

5. Immune checkpoint inhibitor-induced inflammatory arthritis persists after immunotherapy cessation. Issue 3 (20th September 2019)

Authors:
Braaten, Tawnie J; Brahmer, Julie R; Forde, Patrick M; Le, Dung; Lipson, Evan J; Naidoo, Jarushka; Schollenberger, Megan; Zheng, Lei; Bingham 3rd, Clifton O; Shah, Ami A; Cappelli, Laura C
Journal:
Annals of the rheumatic diseases
Issue:
Volume 79:Issue 3(2020)
Page Start:
332
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

6. Immune-related (IR)-pneumonitis during the COVID-19 pandemic: multidisciplinary recommendations for diagnosis and management. Issue 1 (17th June 2020)

Authors:
Naidoo, Jarushka; Reuss, Joshua E; Suresh, Karthik; Feller-Kopman, David; Forde, Patrick M; Mehta Steinke, Seema; Rock, Clare; Johnson, Douglas B; Nishino, Mizuki; Brahmer, Julie R
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

8. Neoadjuvant nivolumab plus ipilimumab in resectable non-small cell lung cancer. Issue 2 (13th September 2020)

Authors:
Reuss, Joshua E; Anagnostou, Valsamo; Cottrell, Tricia R; Smith, Kellie N; Verde, Franco; Zahurak, Marianna; Lanis, Mara; Murray, Joseph C; Chan, Hok Yee; McCarthy, Caroline; Wang, Daphne; White, James R; Yang, Stephen; Battafarano, Richard; Broderick, Stephen; Bush, Errol; Brock, Malcolm; Ha, Ji...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 8:Issue 2(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

9. Peripheral blood immune cell dynamics reflect antitumor immune responses and predict clinical response to immunotherapy. Issue 6 (10th June 2022)

Authors:
Hwang, Michael; Canzoniero, Jenna Vanliere; Rosner, Samuel; Zhang, Guangfan; White, James R; Belcaid, Zineb; Cherry, Christopher; Balan, Archana; Pereira, Gavin; Curry, Alexandria; Niknafs, Noushin; Zhang, Jiajia; Smith, Kellie N; Sivapalan, Lavanya; Chaft, Jamie E; Reuss, Joshua E; Marrone, Kris...
Journal:
Journal for immunotherapy of cancer
Issue:
Volume 10:Issue 6(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

10. Protocol of DREAM3R: DuRvalumab with chEmotherapy as first-line treAtment in advanced pleural Mesothelioma—a phase 3 randomised trial. Issue 1 (25th January 2022)

Authors:
Kok, Peey Sei; Forde, Patrick M; Hughes, Brett; Sun, Zhuoxin; Brown, Chris; Ramalingam, Suresh; Cook, Alistair; Lesterhuis, Willem Joost; Yip, Sonia; O'Byrne, Ken; Pavlakis, Nick; Brahmer, Julie; Anagnostou, Valsamo; Ford, Kate; Fitzpatrick, Karen; Bricker, Alison; Cummins, Michelle M; Stockler, ...
Journal:
BMJ open
Issue:
Volume 12:Issue 1(2022)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗